Key result
Bioprosthetic valve fracture is linked to reduced patient-prosthesis mismatch during ViV-TAVI, including in females.
Why the study?
Female sex and valve-in-valve TAVI are both associated with patient-prosthesis mismatch, yet whether sex-specific differences exist in patient-prosthesis mismatch rates following valve-in-valve TAVI was uncertain.
Do sex-specific differences exist in rates of patient-prosthesis mismatch and the impact of bioprosthetic valve fracture following valve-in-valve transcatheter aortic valve implantation?
Observational (n=77)
No
Do sex-specific differences exist in rates of patient-prosthesis mismatch and the impact of bioprosthetic valve fracture following valve-in-valve transcatheter aortic valve implantation?
Rates of patient-prosthesis mismatch following valve-in-valve TAVI were similar between sexes, though bioprosthetic valve fracture was significantly associated with reduced mismatch particularly in females.
Answers are grounded in this paper and cite their sources.
BVF was associated with reduced PPM in females; hypothesis-generating for sex-specific valve-in-valve strategies.
Female sex is associated with increased rates of mortality and readmission following transcatheter aortic valve implantation (TAVI) and is a risk factor for patient-prosthesis mismatch (PPM). Valve-in-valve (ViV) TAVI for treatment of degenerated bioprosthetic valves has a greater risk of PPM. We sought to determine if sex-specific differences exist in rates of PPM following ViV-TAVI. This retrospective study analyzed 77 patients who underwent ViV-TAVI at Kettering Health from 2015 to 2021, evaluating PPM incidence and bioprosthetic valve fracture (BVF) utilization. Indexed effective orifice area following ViV-TAVI was compared between females and males using an unpaired t test. Fisher exact test assessed the association between BVF and PPM for the overall cohort and within each sex. Statistical analyses were performed using R software. Males represented 57% of patients (body mass index = 28.8 kg/m 2 ), while females comprised 43% (body mass index = 29.1 kg/m 2 ). There was no significant difference in average indexed effective orifice area between females and males ( P = .370). BVF rates were similar between sexes (33.3% in females; 29.6% in males), with an overall reduction in PPM ( P = .028) and in females ( P = .029). Cramér’s V showed a moderate association between BVF and PPM in the overall cohort (0.305) and females (0.475), with a weaker association in males (0.183). Similar rates of PPM between sexes suggest that appropriate patient selection and valve sizing are crucial in PPM prevention. The significant reduction of PPM with BVF in females calls for further research into sex-specific outcomes and optimization of ViV-TAVI results.
No takes yet. Share an insight, caveat, or question.
Reddy et al. (2026) conducted an observational in Degenerated bioprosthetic aortic valves treated with valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) (n=77). Female sex and bioprosthetic valve fracture (BVF) vs. Male sex / no BVF was evaluated on Patient-prosthesis mismatch (PPM) and indexed effective orifice area following ViV-TAVI (Cramér's V 0.475 (BVF and PPM in females), p=0.370 (sex difference in indexed EOA); 0.029 (PPM reduction with BVF in females)). Female sex did not differ from male sex in post-ViV-TAVI indexed EOA, while bioprosthetic valve fracture reduced PPM overall and in females.
Synapse has enriched 10 related papers. Consider them for comparative context: